Jörg Ellinger
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 33
-
- Prostate Cancer Treatment and Research 47
- Renal cell carcinoma treatment 30
- Prostate Cancer Diagnosis and Treatment 27
- Molecular Biology top 1%
- Epigenetics and DNA Methylation 50
- RNA modifications and cancer 26
- Cancer-related gene regulation 24
- Oncology top 2%
- Surgery top 5%
- Bladder and Urothelial Cancer Treatments 33
- Co-authors
- Stefan C. MüllerAlexander von RueckerPatrick J. BastianGlen KristiansenLukas C. HeukampPhilip KahlDoris SchmidtStefan Hauser
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Jörg Ellinger
203 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 131
- Cancer Research 2.6k
- Pulmonary and Respiratory Medicine 2.0k
- Molecular Biology 4.2k
- Oncology 1.0k
- Surgery 902
Countries citing papers authored by Jörg Ellinger
This map shows the geographic impact of Jörg Ellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Ellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Ellinger more than expected).
Fields of papers citing papers by Jörg Ellinger
This network shows the impact of papers produced by Jörg Ellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Ellinger. The network helps show where Jörg Ellinger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jörg Ellinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 4 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 6 | |
| 14 | 2022 | 53 | |
| 15 | 2022 | 14 | |
| 16 | 2022 | 1 | |
| 17 | 2021 | 23 | |
| 18 | 2015 | 167 | |
| 19 | Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer. | 2012 | 32 |
| 20 | Modifications of metabolic adaptations to fasting by low dose oral glucose | 1976 | 1 |
About Jörg Ellinger
Jörg Ellinger is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Urology, having authored 221 papers that have together received 6.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (50 papers), Prostate Cancer Treatment and Research (47 papers), Cancer-related molecular mechanisms research (33 papers), Bladder and Urothelial Cancer Treatments (33 papers), Renal cell carcinoma treatment (30 papers), Prostate Cancer Diagnosis and Treatment (27 papers), RNA modifications and cancer (26 papers) and Cancer-related gene regulation (24 papers). The work is most often cited by research in Cancer Research (2.6k citations), Pulmonary and Respiratory Medicine (2.0k citations) and Molecular Biology (4.2k citations). Jörg Ellinger has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Stefan C. Müller, Alexander von Ruecker, Patrick J. Bastian, Glen Kristiansen, Lukas C. Heukamp, Philip Kahl, Doris Schmidt, Stefan Hauser, Sebastian Rogenhofer and Stefan Holdenrieder. Their work appears in journals such as The Journal of Urology, Cancers, British Journal of Urology, World Journal of Urology and International Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.